The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2024

Filed:

Mar. 21, 2018
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Universite D'orleans, Orleans, FR;

Inventors:

Lucie Pigeon, Olivet, FR;

Rachid A. Rahmouni, Germigny des Pre, FR;

Harivony Chantal Pichon-Rabenandrasana, St Denis de L'Hôtel, FR;

Patrick Midoux, Saint Denis de L'Hôtel, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P 19/34 (2006.01); A61K 31/7088 (2006.01); C07K 14/395 (2006.01); C12N 15/81 (2006.01);
U.S. Cl.
CPC ...
C12P 19/34 (2013.01); A61K 31/7088 (2013.01); C07K 14/395 (2013.01); C12N 15/81 (2013.01);
Abstract

The application relates to the production of RNA of interest, more specifically of messenger RNA of interest or of long non-coding RNA of interest, by yeasts with recombinant pseudo-viral particles. The recombinant yeasts have been genetically modified in order to produce the RNA of interest in the form of a complex, particularly in the form of recombinant pseudo-viral particles. These recombinant pseudo-viral particles are produced from certain elements of yeast Ty retrotransposon, but do not retrotranscribe the RNA that they contain. Thus, the application relates to the components that are thus capable of being implemented or produced, and particularly to the nucleic acid constructs, kits, bacteria cells, yeast cells, culture or transfection media containing them, as well as to a method for producing a pharmaceutical composition, particularly for medical applications, more specifically for vaccines, anti-tumour and pro-regenerative applications.


Find Patent Forward Citations

Loading…